May 6 |
Analyst Expectations For Stoke Therapeutics's Future
|
May 6 |
Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates
|
May 6 |
Stoke Therapeutics GAAP EPS of -$0.57, revenue of $4.2M
|
May 6 |
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
|
Apr 29 |
Stoke Therapeutics appoints CFO
|
Apr 29 |
Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer
|
Apr 25 |
Earnings Preview: Stoke Therapeutics, Inc. (STOK) Q1 Earnings Expected to Decline
|
Apr 17 |
Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer
|
Apr 4 |
Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
|
Apr 4 |
Stoke Therapeutics: Positive Dravet Data Sends Shares Soaring, One For The Watchlist
|